CNSX:PREV PreveCeutical Medical (PREV) Stock Price, News & Analysis → IRS Loophole Gives Americans An Escape From Inflation (From Birch Gold) (Ad) Free PREV Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume694,224 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get PreveCeutical Medical alerts: Email Address Ad Birch GoldIRS Loophole Gives Americans An Escape From InflationIn the years immediately following 2008-09, as the economy stagnated, gold exploded in value. Today, Goldman Sachs is telling its clients that gold may reach $2,250 within the next few years. Don't miss your chance to diversify your savings.Request your info kit on gold now About PreveCeutical MedicalPreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.Read More Ad Birch GoldIRS Loophole Gives Americans An Escape From InflationIn the years immediately following 2008-09, as the economy stagnated, gold exploded in value. Today, Goldman Sachs is telling its clients that gold may reach $2,250 within the next few years. Don't miss your chance to diversify your savings.Request your info kit on gold now PREV Stock News HeadlinesDecember 4, 2023 | finance.yahoo.comPREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAMNovember 24, 2023 | finance.yahoo.comPreveCeutical Medical Inc. (PREV.CN)April 18, 2024 | Birch Gold (Ad)IRS Loophole Gives Americans An Escape From InflationIn the years immediately following 2008-09, as the economy stagnated, gold exploded in value. Today, Goldman Sachs is telling its clients that gold may reach $2,250 within the next few years. Don't miss your chance to diversify your savings.September 12, 2023 | forbes.comAnswering All Your Questions About Medical Alert SystemsAugust 31, 2023 | finance.yahoo.comPreveCeutical Engages New to the Street for Production & Broadcasting ServicesJuly 24, 2023 | finance.yahoo.comPreveCeutical Files Cyclic Peptides And Uses Thereof in the EU and AustraliaJuly 15, 2023 | finance.yahoo.comPRVCF - PreveCeutical Medical Inc.April 27, 2023 | cnet.comHigher Credit Scores: New Medical Debt Rules Could Give a BoostApril 18, 2024 | Birch Gold (Ad)IRS Loophole Gives Americans An Escape From InflationIn the years immediately following 2008-09, as the economy stagnated, gold exploded in value. Today, Goldman Sachs is telling its clients that gold may reach $2,250 within the next few years. Don't miss your chance to diversify your savings.March 23, 2023 | finanznachrichten.dePreveCeutical Medical Inc.: PreveCeutical Initiates Non-Analgesic (Painkiller) Program, Clinical Development Program & Disclosure CommitteeMarch 6, 2023 | finanznachrichten.dePreveCeutical Medical Inc.: PreveCeutical - International Filing of Thermoresponsive Sol-Gels Containing Cannabinoids & Uses ThereofMarch 6, 2023 | finance.yahoo.comPreveCeutical - International Filing of Thermoresponsive Sol-Gels Containing Cannabinoids & Uses ThereofJanuary 25, 2023 | finance.yahoo.comPreveCeutical - Australian Patent Granted for Disulfide Bond Containing CompoundsJanuary 23, 2023 | finance.yahoo.comPreveCeutical - Background IP, US Patent Granted Disulfide Bond Containing CompoundsJanuary 17, 2023 | finanznachrichten.dePreveCeutical Medical Inc.: PreveCeutical - Dynorphin Peptides (Painkiller) and Uses Thereof Patent Update and Officer UpdateJanuary 17, 2023 | finance.yahoo.comPreveCeutical - Dynorphin Peptides (Painkiller) and Uses Thereof Patent Update and Officer UpdateJuly 24, 2022 | yahoo.comAaron Donald is in Madden’s 99 Club for 6th year in a rowJuly 24, 2022 | seekingalpha.comPreveCeutical Medical enters into $3M credit facilityJuly 22, 2022 | finance.yahoo.comPreveCeutical Enters into Credit Facility AgreementMay 29, 2022 | finanznachrichten.dePreveCeutical Medical Inc.: PreveCeutical Announces Change in Directors and Investor Awareness ServicesMay 11, 2022 | finanznachrichten.dePreveCeutical Medical Inc.: Article Based on PreveCeutical's Pain Management Peptides Program Published in the British Journal of PharmacologyApril 4, 2022 | investing.comPreveCeutical Medical Inc (PREV)February 15, 2022 | msn.comConverting Cannabis Liquid To Gel Form: Is It Revolutionary For The Marijuana Industry?January 17, 2022 | nasdaq.comPreveCeutical Medical Inc (PRVCF)January 13, 2022 | finance.yahoo.comSettlement Reached in Tietz Class Action LawsuitOctober 6, 2021 | finance.yahoo.comCaroline MacCallum, MD, FRCPC, BSc Pharm, Joins PreveCeuticalAugust 19, 2021 | barrons.comPreveCeutical Medical Inc.See More Headlines Receive PREV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PreveCeutical Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCNSX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCNSX:PREV CUSIPN/A CIKN/A Webwww.preveceutical.com Phone604-416-7777FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Stephen Van Deventer (Age 54)Chairman & CEO Comp: $123.17kDr. Makarand Jawadekar Ph.D. (Age 72)Chief Science Officer, Pres & Director Comp: $75.17kMs. Shabira Rajan CPA (Age 67)CGA, CFO & Controller Comp: $82.1kDr. Harendra Parekh Ph.D.BSc., Hons I, MRPharmS, Chief Research OfficerKey Competitors45525 (CUR.TO)TSE:CURCanada House Wellness GroupCNSX:CHVDirexion Daily Healthcare Bull 3X SharesCNSX:CUREMatica EnterprisesCNSX:MMJSonicShares Airlines, Hotels, Cruise Lines ETFCNSX:TRYPView All Competitors PREV Stock Analysis - Frequently Asked Questions What other stocks do shareholders of PreveCeutical Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other PreveCeutical Medical investors own include Aurora Cannabis (ACB), Equinix (EQIX), PreveCeutical Medical (PRVCF), Blue Energy (BLU), Biocept (BIOC), Baidu (BIDU), BlackBerry (BB), Alimentation Couche-Tard (ATD.B), Amarin (AMRN). How do I buy shares of PreveCeutical Medical? Shares of PREV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (CNSX:PREV) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold[Urgent!] Generational Wealth GameplanCrypto 101 MediaIRS Loophole Gives Americans An Escape From InflationBirch GoldHe Is Giving Away BitcoinCrypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PreveCeutical Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.